Adetola Kassim Archive — Page 1 of 1
-
June 25, 2024
International trial introduces another curative option for sickle cell disease
The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments. -
April 24, 2024
VUMC hosts symposium on stem cell transplants and cellular therapies
The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.